IBM, Public Health Groups Form Global Pandemic Initiative

IBM and over twenty major worldwide public health institutions, including the World Health Organization and the Centers for Disease Control and Prevention, announced the Global Pandemic Initiative, a collaborative effort to help stem the spread of infectious diseases.

With growing concerns over potential outbreaks of new strains of disease, and their ability to spread more easily because of modern transportation, IBM scientists have formed a steering committee with worldwide health organizations and universities to guide efforts to address the issue. Together, they will explore the use of advanced analytical and computer technology as part of a global preparedness program for responding to potential infectious disease outbreaks around the world.

IBM will bring to bear several of its key technologies and is establishing healthcare "Innovation Centers" at the company's worldwide Research laboratories to work with the global healthcare community in this collaborative effort.

"The threat of a pandemic is a definitively global phenomenon," said Samuel J. Palmisano, IBM's chairman and chief executive officer. "Our response must be similarly global, and must rely -- as with so many other major issues we face today -- on open, collaborative innovation. IBM is proud to join with our partners in this effort, grounded in our core value of 'innovation that matters.'"

Central to the effort will be the use of advanced software technologies, elements of which IBM intends to contribute to the open-source community, that are designed to help share information on disease outbreaks electronically and use it to predict how diseases will spread.

Among the technologies that will be used is a software framework IBM developed to allow electronic health information to be more easily shared and mined for trends, such as the outbreak of disease. Called the Interoperable Healthcare Information Infrastructure (IHII), the technology is designed to improve communication and collaboration among medical professionals and researchers by helping them collect and share health data. IBM will expand the role of IHII to include public health issues, responding to global calls for pandemic preparedness by facilitating the sharing of clinical data among medical facilities, laboratories and public health agencies.

IBM also plans to build a community of users around its epidemiological modeling framework, called Spatio-Temporal Epidemiological Modeller (STEM), which can tap the information collected from IHII, along with additional information such as roadmaps, airport locations, travel patterns, and bird migration routes around the world. It will allow users to rapidly develop models for how a disease is likely to geographically spread over time. These models can help public health experts and governmental planners develop more effective preparedness plans.

Ultimately, those plans could include development and distribution of more effective and timely vaccines as IBM taps into knowledge gained through a planned collaborative initiative known as "Project Checkmate," in which IBM and The Scripps Research Institute propose to conduct advanced biological research on influenza viruses. The collaboration is designed to predict the way viruses will mutate over time using advanced predictive techniques running on high performance computing systems, such as IBM's BlueGene supercomputer, allowing effective vaccines to be developed by drug-makers, drawing on the immunology and chemistry expertise at Scripps.

IBM scientists at the company's Research Labs in China, India, Israel, Japan, Switzerland and the U.S. will serve as focal points for the collaboration. Among the members of the Pandemic Initiative steering committee are: US Agency for International Development, Centers for Disease Control and Prevention, World Health Organization, Scripps Research Institute, University of Pittsburgh Medical Center - Center for Biosecurity.

Contact information:
Michael Loughran
IBM Media Relations
914.945.1613
This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...